Ronald Breaker

From Wikipedia, the free encyclopedia
Ronald R. Breaker
NationalityAmerican
Alma materUniversity of Wisconsin–Stevens Point, Purdue University, Scripps Research Institute
Known forRiboswitches, Ribozymes, Deoxyribozymes
AwardsBeckman Young Investigators Award[1]
Scientific career
FieldsBiochemistry, Molecular Biology
InstitutionsYale University
Doctoral advisorPeter T. Gilham
Other academic advisorsGerald Joyce

Ronald R. Breaker, Ph.D. (born 1964) is the Sterling Professor of Molecular, Cellular, and Developmental Biology at Yale University. He earned his B.S. in Biology and Chemistry from the University of Wisconsin–Stevens Point and his Ph.D. in Biochemistry from Purdue University. He was a postdoctoral fellow at The Scripps Research Institute under the supervision of Gerald Joyce. While at Scripps, he isolated the first DNA enzyme (deoxyribozyme). He then began his independent career at Yale University. Among his major accomplishments is the discovery of riboswitches.[2] His current research is focused on understanding advanced functions of nucleic acids, including the discovery and analysis of riboswitches and ribozymes. He has been a Howard Hughes Medical Institute (HHMI) Investigator since 2005.[3]

Breaker is a member of the JASON defense advisory group, and was elected to the U.S. National Academy of Sciences in 2013.[4]

Awards[]

References[]

  1. ^ "Ronald Breaker". Arnold and Mabel Beckman Foundation. Retrieved 1 August 2018.
  2. ^ Yarnell, Amanda (23 March 2004). "Ronald Breaker". C&EN. Retrieved 14 February 2013.
  3. ^ "Ronald R. Breaker". HHMI. HHMI. Retrieved 14 February 2013.
  4. ^ "Ronald Breaker, Ph.D."

External links[]

Retrieved from ""